National Health Investors, Inc. (NHI) to Issue Quarterly Dividend of $0.92 on January 30th

National Health Investors, Inc. (NYSE:NHI) declared a quarterly dividend on Thursday, November 6th. Investors of record on Wednesday, December 31st will be given a dividend of 0.92 per share by the real estate investment trust on Friday, January 30th. This represents a c) annualized dividend and a yield of 4.8%. The ex-dividend date of this dividend is Wednesday, December 31st.

National Health Investors has decreased its dividend payment by an average of 0.0%annually over the last three years. National Health Investors has a payout ratio of 112.5% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Research analysts expect National Health Investors to earn $4.66 per share next year, which means the company should continue to be able to cover its $3.68 annual dividend with an expected future payout ratio of 79.0%.

National Health Investors Price Performance

Shares of NYSE NHI opened at $76.97 on Friday. The stock’s 50-day simple moving average is $76.78 and its two-hundred day simple moving average is $74.38. National Health Investors has a twelve month low of $65.13 and a twelve month high of $82.32. The firm has a market capitalization of $3.65 billion, a P/E ratio of 24.59, a P/E/G ratio of 3.31 and a beta of 0.74. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, topping the consensus estimate of $1.24 by $0.08. The company had revenue of $83.36 million during the quarter, compared to analyst estimates of $85.66 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.National Health Investors’s revenue was down 1.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.03 earnings per share. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. As a group, equities analysts anticipate that National Health Investors will post 4.41 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Wells Fargo & Company increased their price target on shares of National Health Investors from $76.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 27th. Weiss Ratings reiterated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. Truist Financial raised their price target on National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Cantor Fitzgerald initiated coverage on National Health Investors in a research note on Wednesday, October 1st. They set an “overweight” rating and a $90.00 price target for the company. Finally, National Bankshares set a $90.00 price objective on National Health Investors in a report on Wednesday, October 1st. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $84.83.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.